- Vienna '18
- Athens 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: A.Bikbulatova RUSSIA
Co Author(s): M. Bikbov R. Mannanova
Back to previous
To evaluate the results of implantation of a sulcus fixated Sulcoflex supplementary intraocular lens (IOL) to correct pseudophakic ametropia in adults and children.
Ufa Eye Research Institute, Russia
15 aspheric and 6 toric Sulcoflex supplementary IOLs (Rayner) were implanted in 21 patients aged from 9 to 70 (Mḟm=26.53ḟ4.40) years old with residual ametropia. In children ametropia was complicated by amblyopia. The period after cataract surgery was from 2 months to 7 years. The range of preoperative spherical equivalent was between -5.00 to 4.50 D. The maximal astigmatism was 3.00 D. The postoperative target refraction for all eyes was emmetropia. Inclusion criterions for Sulcoflex IOLs implantation were intracapsular fixation of first IOL, Zinn Zonule integrity, and normal hydrodynamics. The mean postoperative follow-up period was 3 years.
The postoperative uncorrected visual acuity was equal or higher than preoperative corrected visual acuity. The mean spherical equivalent was 0.14ḟ0.16 D. Improvement of contrast sensitivity function and decrease of aberrations were achieved after Sulcoflex IOLs implantation. There were no significant postoperative complications. During the follow-up period the transparent distance between the primary IOL and secondary IOL were observed in all cases. Sulcoflex IOLs had stable position.
Implantation of Sulcoflex supplementary IOL into the pseudophakic eye is a safe, effective and quit simple way to correct residual ametropia in adults and children.